Item 1A. Risk Factors
Item
1A. Risk Factors
The
risk factors in this section describe the material risks to our business, prospects, results of operations, financial condition
or cash flows, and should be considered carefully. In addition, these factors constitute our cautionary statements under the Private
Securities Litigation Reform Act of 1995 and could cause our actual results to differ materially from those projected in any forward-looking
statements (as defined in such act) made in this annual report on Form 10-K. Investors should not place undue reliance on any
such forward-looking statements. Any statements that are not historical facts and that express, or involve discussions as to,
expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, through the use
of words or phrases such as “will likely result,” “are expected to,” “will continue,” “is
anticipated,” “estimated,” “intends,” “plans,” “believes” and “projects”)
may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from
those expressed in the forward-looking statements.
Further,
any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update
any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect
the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible
for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or
the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained
in any forward-looking statements.
Risks
Related to Our Business
We
have a history of net losses and we are uncertain about our future profitability.
We
have incurred significant net losses since our inception. For the years ended December 31, 2020, 2019, and 2018, we have incurred
net losses of $2.7 million, $1.4 million, and $1.2 million, respectively. As of December 31, 2020, we had an accumulated deficit
of approximately $13.8 million. If our revenue grows more slowly than currently anticipated, or if operating expenses are
higher than expected, we may be unable to consistently achieve profitability, our financial condition will suffer, and the value
of our common stock could decline. Even if we are successful increasing our sales, we may incur losses in the foreseeable future
as we continue to develop and market our products.
If
sales revenue from any of our current products or any additional products that we develop in the future is insufficient, or if
our product development is delayed, we may be unable to achieve profitability and, in the event we are unable to secure financing
for prolonged periods of time, we may need to temporarily cease operations and, possible, shut them down altogether. Furthermore,
even if we are able to achieve profitability, we may be unable to sustain or increase such profitability on a quarterly or annual
basis, which would adversely impact our financial condition and significantly reduce the value of our common stock.
7
If
we are unable to continue as a going concern, our securities will have little or no value.
The
report of our independent registered public accounting firm that accompanies our audited consolidated financial statements for
the years ended December 31, 2020 and December 31, 2019 contain a going concern qualification in which such firm expressed substantial
doubt about our ability to continue as a going concern. These factors raise substantial doubt about our ability to continue as
a going concern. Our consolidated financial statements do not include any adjustments that might result if we are unable to continue
as a going concern. If we are unable to continue as a going concern, holders of our securities might lose their entire
investment. We plan to attempt to raise additional through one or more private placement or public offerings. However, the doubts
raised relating to our ability to continue as a going concern may make our shares an unattractive investment for potential investors.
These factors, among others, may make it difficult to raise any additional capital and may cause us to be unable to continue to
operate our business.
Our
operations have been affected by the COVID-19 pandemic.
In
March 2020, the World Health Organization declared the outbreak of a novel coronavirus (“COVID-19”) a global pandemic
prompting government-imposed quarantines, suspension of in-person attendance of academic programs, and cessation of certain travel
and business closures. The United States has entered a recession as a result of the COVID-19 pandemic, which may prolong and exacerbate
the negative impact on us. Although we expect the availability of vaccines and various treatments with respect to COVID-19 to
have an overall positive impact on business conditions in the aggregate over time, the exact timing of these positive developments
is uncertain. In December 2020, the United States began distributing two vaccines that, in addition to other vaccines under development,
are expected to help to reduce the spread of the coronavirus that causes COVID-19 once they are widely distributed. If the vaccines
prove less effective than currently understood by the scientific community and the United States Food and Drug Administration,
or if there are problems with the acceptance, availability, timing or other difficulties with widely distributing the vaccines,
the pandemic may last longer, and could continue to impact our business for longer, than we currently expect. In response to COVID-19,
governmental authorities have implemented numerous measures to try to contain the virus, such as travel bans and restrictions,
prohibitions on group events and gatherings, shutdowns of certain businesses, curfews, shelter in place orders and recommendations
to practice social distancing. Although many governmental measures have had specific expiration dates, some of those measures
have already been extended more than once, and there is considerable uncertainty regarding the duration of such measures and the
implementation of any potential future measures, especially if cases increase again across the United States, with the potential
for additional challenges resulting from the emergence of new variants of COVID-19, some of which may be more transmissible than
the initial strain. Such measures have impacted, and may continue to affect, our workforce, operations, suppliers and customers.
We reduced the size of our workforce following the onset of COVID-19 and may need to take additional actions to further reduce
the size of our workforce in the future; such reductions incur costs, and we can provide no assurance that we will be able to
rehire our workforce in the event our business experiences a subsequent recovery. We took steps to curtail our operating expenses
and conserve cash. We may elect or need to take additional remedial measures in the future as the information available to us
continues to develop, including with respect to our workforce, relationships with our third-party vendors, and our customers.
There is no certainty that the remedial measures we have implemented to date, or any additional remedial steps we may take in
the future, will be sufficient to mitigate the risks posed by COVID-19. Further, such measures could potentially materially adversely
affect our business, financial condition and results of operations and create additional risks for us. Any escalation of COVID-19
cases across many of the markets we serve could have a negative impact on us. Specifically, we could be adversely impacted by
limitations on our employees to perform their work due to illness caused by the pandemic or local, state, or federal orders requiring
our stores to close or employees to remain at home; limitation of carriers to deliver our product to customers; product shortages;
limitations on the ability of our customers to conduct their business and purchase our products and services; and limitations
on the ability of our customers to pay us in a timely manner. These events could have a material, adverse effect on our results
of operations, cash flows and liquidity.
The
ultimate magnitude of COVID-19, including the full extent of the material negative impact on our financial and operational results,
will depend on future developments. The resumption of our normal business operations may be delayed or constrained by lingering
effects of COVID-19 on our customers, suppliers and/or third-party service providers. Furthermore, the extent to which our mitigation
efforts are successful, if at all, is not currently ascertainable. Due to the daily evolution of the COVID-19 pandemic and the
responses to curb its spread, we cannot predict the full impact of the COVID-19 pandemic on our business and results of operations,
but our business, financial condition, results of operations and cash flows have already been materially adversely impacted, and
we anticipate they will continue to be adversely affected by the COVID-19 pandemic and its negative effects on global economic
conditions. Any recovery from the COVID-19 pandemic and related economic impact may also be slowed or reversed by a variety of
factors, such as any increase in COVID-19 infections. Even after the COVID-19 pandemic has subsided, we may continue to experience
adverse impacts to our business as a result of its national and, to some extent, global economic impact, including the current
recession and any recession that may occur in the future.
The
success of our business depends on our global operations, including our supply chain and consumer demand, among other things.
As a result of COVID-19, we have experienced shortages in inventory due to manufacturing issues, a reduction in the volume of
sales in some parts of our business, such as rental sales and direct website sales, and a reduction in personnel due to lockdown
related issues. Our results of operations for the year ended December 31, 2020 reflect this impact; however, we expect that this
trend may continue and the full extent of the impact is unknown. In recent months, some governmental agencies in the US and Europe,
where we produce the largest percentage of our sales, have lifted certain restrictions. However, if customer demand continues
to be low, our future equipment sales, subscriber activations and sales margin will be impacted.
Our
dependence on key suppliers puts us at risk of interruptions in the availability of our products, which could reduce our revenue
and adversely affect our results of operations. In addition, increases in prices for components used in our products could adversely
affect our results of operations.
We
require the timely delivery of products provided by our suppliers, some of which are custom made, to ensure our ongoing sales
revenue is not adversely affected. For reasons of quality assurance, cost effectiveness or availability, we procure certain products
from a single or limited number of suppliers. We generally acquire such products through purchase orders placed in the ordinary
course of business, and as a result we may not have a significant inventory of these products and generally do not have any guaranteed
or contractual supply arrangements with many of these suppliers. Our reliance on these suppliers subjects us to risks that could
harm our business, including, but not limited to, difficulty locating and qualifying alternative suppliers and limited control
over pricing, availability, quality and delivery schedules. Suppliers of products may decide, or be required, for reasons beyond
our control, to cease supplying materials and components to us or to raise their prices. Shortages of materials, quality control
problems, production capacity constraints or delays by our suppliers could negatively affect our ability to meet our production
requirements and result in increased prices for affected products. We may also face delays, yield issues and quality control problems
if we are required to locate and secure new sources of supply. Any material shortage, constraint or delay may result in delays
in shipments of our products, which could materially adversely affect our results of operations. Increases in prices for materials
and components used in our products could also materially adversely affect our results of operations.
8
The
United Kingdom’s departure from the EU could adversely affect us.
We
sell our products and services in the United Kingdom (the “UK”) and throughout Europe. In particular, the UK is one
of our largest markets in Europe for product and airtime sales. On June 23, 2016, the UK voted in an advisory referendum for the
UK to leave the European Union (the “EU”) and, subsequently, on March 29, 2017, the UK government began the formal
process of leaving the EU (“Brexit”). The UK withdrew from the EU on January 31, 2020. Effective January 1, 2021,
the EU and UK entered into the Trade and Cooperation Agreement regarding trade policies and other political and strategic issues.
The future consequences of Brexit are unknown at this time, but Brexit has created legal, regulatory, and currency risk that may
have a materially adverse impact on our business. Furthermore, this uncertainty could negatively impact the economies of other
countries in which we operate.
The
decision by British voters to exit the European Union may negatively impact our operations, pricing and profitability.
The
June 2016 referendum by British voters to exit the European Union (“Brexit”) adversely impacted global markets and
resulted in a sharp decline in the value of the British pound, as compared to the U.S. dollar and other currencies. Following
the U.K.’s departure from the European Union on December 31, 2020 volatility in exchange rates and in U.K. interest rates
may continue. In the near term, a weaker British pound compared to the U.S. dollar during a reporting period causes local currency
results of our U.K. operations to be translated into fewer U.S. dollars; a weaker British pound compared to other currencies increases
the cost of goods imported into our U.K. operations and may decrease the profitability of our U.K. operations; and a higher U.K.
interest rate may have a dampening effect on the U.K. economy. In the longer term, any impact from Brexit on our U.K. operations
will depend, in part, on the effect of the trade and regulatory terms of the Brexit agreement announced on December 23, 2020 and
which took effect on January 1, 2021.
We
may need to raise additional capital to grow our business and satisfy our anticipated future liquidity needs, and we may not be
able to raise it on terms acceptable to us, or at all.
Growing
and operating our business will require significant cash outlays, liquidity reserves and capital expenditures and commitments
to respond to business challenges, including developing or enhancing new or existing products. As of December 31, 2020,
we had cash on hand of $728,762. If cash on hand, cash generated from operations, and the net proceeds from this offering
are not sufficient to meet our cash and liquidity needs, we may need to seek additional capital, potentially through debt or equity
financings. To the extent that we raise additional capital through the sale of additional equity or convertible securities, your
ownership interest may be diluted, and the terms of these securities may include liquidation or other preferences that adversely
affect your rights as a stockholder. Debt financing, if available, would result in increased fixed payment obligations and a portion
of our operating cash flows, if any, being dedicated to the payment of principal and interest on such indebtedness. In addition,
debt financing may involve agreements that include restrictive covenants that impose operating restrictions, such as restrictions
on the incurrence of additional debt, the making of certain capital expenditures or the declaration of dividends. Any additional
fundraising efforts may divert our management from their day-to-day activities, which may adversely affect our ability to develop
and commercialize our products. Even if we believe we have sufficient funds for our current or future operating plans, we may
seek additional capital if market conditions are favorable or in light of specific strategic considerations. If we are unable
to obtain funding on a timely basis, we may be required to significantly curtail, delay or discontinue one or more of our research
or product candidate development programs or the commercialization of any product candidate or be unable to expand our operations
or otherwise capitalize on our business opportunities, as desired, which could materially affect our business, operating results
and prospects and cause the price of the common stock to decline.
9
Product
development is a long, expensive and uncertain process.
The
development of our own branded range of satellite tracking devices is a costly, complex and time-consuming process, and the investment
in product development often involves a long wait until a return, if any, is achieved on such investment. Investments in new technology
and processes are inherently speculative. We have experienced numerous setbacks and delays in our research and development efforts
and may encounter further obstacles in the course of the development of additional technologies and products. We may not be able
to overcome these obstacles or may have to expend significant additional funds and time. Technical obstacles and challenges we
encounter in our research and development process may result in delays in or abandonment of product commercialization, may substantially
increase the costs of development, and may negatively affect our results of operations.
Concentration
of ownership by our principal stockholders may result in control by such stockholders of the composition of our board of directors.
Our
existing principal stockholders, executive officers, directors and their affiliates beneficially own a significant number of our
outstanding shares of common stock. In addition, such parties may acquire additional control by purchasing stock that we may issue
in connection with our future fundraising efforts. Also, the holders of our convertible promissory notes, in the aggregate, upon
conversion at the holders’ option, at various conversion prices, would be issued 4,436,227 shares of our common stock. As
a result, these current and future stockholders may now and in the future be able to exercise a significant level of control over
all matters requiring stockholder approval, including the election of directors. This control could have the effect of delaying
or preventing a change of control of our company or changes in management and will make the approval of certain transactions difficult
or impossible without the support of these stockholders.
Successful
technical development of our products does not guarantee successful commercialization.
We
may successfully complete the technical development for one or all of our product development programs, but still fail to develop
a commercially successful product for a number of reasons, including among others the following:
●
failure
to obtain the required regulatory approvals for their use;
●
prohibitive
production costs;
●
competing
products;
●
lack
of innovation of the product;
●
ineffective
distribution and marketing;
●
failure
to gain market acceptance;
●
lack
of sufficient cooperation from our partners; and
●
demonstrations
of the products not aligning with or meeting customer needs.
Our
success in the market for the products we develop will depend largely on our ability to prove our products’ capabilities.
Upon demonstration, our satellite ground stations and tracking devices may not have the capabilities they were designed to have
or that we believed they would have. Furthermore, even if we do successfully demonstrate our products’ capabilities, potential
customers may be more comfortable doing business with a larger, more established, more proven company than us. Moreover, competing
products may prevent us from gaining wide market acceptance of our products. Significant revenue from new product investments
may not be achieved for a number of years, if at all.
10
Other
companies may claim that we infringe their intellectual property, which could materially increase our costs and harm our ability
to generate future revenue and profit.
We
do not believe that we infringe the proprietary rights of any third party, but claims of infringement are becoming increasingly
common and third parties may assert infringement claims against us. It may be difficult or impossible to identify, prior to receipt
of notice from a third party, the trade secrets, patent position or other intellectual property rights of a third party, either
in the United States or in foreign jurisdictions. Any such assertion may result in litigation or may require us to obtain a license
for the intellectual property rights of third parties. If we are required to obtain licenses to use any third-party technology,
we would have to pay royalties, which may significantly reduce any profit on our products or may be prohibitively expensive and
prevent us from continuing to use that technology. In addition, any such litigation, even if without merit, could be expensive
and disruptive to our ability to generate revenue or enter into new market opportunities. If any of our products were found to
infringe other parties’ proprietary rights and we are unable to come to terms regarding a license with such parties, we
may be forced to modify our products to make them non-infringing, to pay substantial damages to our end users to discontinue their
use of or replace infringing technology sold to them with non-infringing technology, or to cease production of such products altogether.
Confidentiality
agreements with employees and third parties may not prevent unauthorized disclosure of trade secrets and other proprietary information,
and our inability to maintain the confidentiality of that information, due to unauthorized disclosure or use, or other event,
could have a material adverse effect on our business.
In
addition to the protection afforded by patents, we seek to rely on trade secret protection and confidentiality agreements to protect
proprietary know-how that is not patentable or that we elect not to patent, processes for which patents are difficult to enforce,
and any other elements of our product discovery and development processes that involve proprietary know-how, information, or technology
that is not covered by patents. Trade secrets, however, may be difficult to protect. We seek to protect our proprietary processes,
in part, by entering into confidentiality agreements with our employees, consultants, advisors, contractors and collaborators.
Although we use reasonable efforts to protect our trade secrets, our employees, consultants, advisors, contractors, and collaborators
might intentionally or inadvertently disclose our trade secret information to competitors. In addition, competitors may otherwise
gain access to our trade secrets or independently develop substantially equivalent information and techniques. Furthermore, the
laws of some foreign countries do not protect proprietary rights to the same extent or in the same manner as the laws of the United
States. As a result, we may encounter significant problems in protecting and defending our intellectual property both in the United
States and abroad. If we are unable to prevent unauthorized material disclosure of our intellectual property to third parties,
or misappropriation of our intellectual property by third parties, we will not be able to establish or maintain a competitive
advantage in our market, which could materially adversely affect our business, operating results and financial condition.
The
nature of our business involves significant risks and uncertainties that may not be covered by insurance or indemnity.
We
develop and sell products where insurance or indemnification may not be available, including:
●
Designing
and developing products using advanced and unproven technologies in intelligence and homeland security applications that are
intended to operate in high demand, high risk situations; and
●
Designing
and developing products to collect, distribute and analyze various types of information.
Failure
of certain of our products could result in loss of life or property damage. Certain products may raise questions with respect
to issues of privacy rights, civil liberties, intellectual property, trespass, conversion and similar concepts, which may raise
new legal issues. Indemnification to cover potential claims or liabilities resulting from a failure of technologies developed
or deployed may be available in certain circumstances but not in others. We are not able to maintain insurance to protect against
all operational risks and uncertainties. Substantial claims resulting from an accident, failure of our product, or liability arising
from our products in excess of any indemnity or insurance coverage (or for which indemnity or insurance is not available or was
not obtained) could harm our financial condition, cash flows, and operating results. Any accident, even if fully covered or insured,
could negatively affect our reputation among our customers and the public, and make it more difficult for us to compete effectively.
Our
sales may be impacted should there be a disruption of service to our Amazon online storefronts.
The
Company’s Amazon online marketplaces represented approximately 73.3% and 56.9% of total sales for the years ended December
31, 2020 and 2019, respectively and we anticipate that these marketplaces will continue to represent a significant portion of
our sales for the foreseeable future. Should there be a disruption of Amazon services or our ability to maintain storefronts with
Amazon, our sales will likely decrease and we would have to seek other distribution methods to sell our products online, which
may be costly.
11
We
are heavily reliant on David Phipps, our Chairman and Chief Executive Officer, and the departure or loss of David Phipps could
disrupt our business.
The
Company depends heavily on the continued efforts of David Phipps, Chairman, Chief Executive Officer and a director. Mr. Phipps
is the founder of GTC and is essential to the Company’s strategic vision and day-to-day operations and would be difficult
to replace. The departure or loss of Mr. Phipps, or the inability to timely hire and retain a qualified replacement, could negatively
impact the Company’s ability to manage its business.
Our
chairman, president, chief executive officer and controlling shareholder, David Phipps, has provided a personal guarantee to secure
a line of credit for the Company.
The
Company’s UK subsidiary, GTCL has an overadvance line of credit with HSBC, for working capital needs. The overadvance limit
is £25,000 or $34,163 at an exchange rate of 1.3665, with interest at 5.50% over Bank of England’s base rate or current
rate of 6.25% variable. The advance is guaranteed by David Phipps, the Company’s Chief Executive Officer. The Company has
an American Express account for Orbital Satcom Corp. and an American Express account for GTCL, both in the name of David Phipps
who personally guarantees the balance owed.
However,
there is potential for conflicts of interest between his personal interests and ours whether his guaranty is called upon or not.
No assurance can be given that material conflicts will not arise that could be detrimental to our operations and financial prospects.
If
we are unable to recruit and retain key management, technical and sales personnel, our business would be negatively affected.
For
our business to be successful, we need to attract and retain highly qualified technical, management and sales personnel. The failure
to recruit additional key personnel when needed with specific qualifications and on acceptable terms or to retain good relationships
with our partners might impede our ability to continue to develop, commercialize and sell our products. To the extent the demand
for skilled personnel exceeds supply, we could experience higher labor, recruiting and training costs in order to attract and
retain such employees. We face competition for qualified personnel from other companies with significantly more resources available
to them and thus may not be able to attract the level of personnel needed for our business to succeed.
Approximately
73.3% of our revenues are from sales of products on Amazon and any limitation or restriction, temporarily or otherwise, to sell
on Amazon’s platform could have a material adverse impact to our business, results of operations, financial condition and
prospects.
Approximately
73.3% of our products are sold on Amazon and are subject to Amazon’s terms of service and various other Amazon seller policies
that apply to third parties selling products on Amazon’s marketplace. Amazon’s terms of service provide, among other
things, that it may terminate or suspend its agreement with any seller or any of its services being provided to a seller at any
time and for any reason. In addition, if Amazon determines that any seller’s actions or performance, including ours, may
result in violations of its terms or policies, or create other risks to Amazon or to third parties, then Amazon may in its sole
discretion withhold any payments owed for as long as Amazon determines any related risk to Amazon or to third parties persist.
Further, if Amazon determines that any seller’s, including our, accounts have been used to engage in deceptive, fraudulent
or illegal activity, or that such accounts have repeatedly violated its policies, then Amazon may in its sole discretion permanently
withhold any payments owed. In addition, Amazon in its sole discretion may suspend a seller account and product listings if Amazon
determines that a seller has engaged in conduct that violates any of its policies. Any limitation or restriction on our ability
to sell on Amazon’s platform could have a material impact on our business, results of operations, financial condition and
prospects. We also rely on services provided by Amazon’s fulfillment platform which provides for expedited shipping to the
consumer, an important aspect in the buying decision for consumers. Any inability to market our products for sale with delivery
could have a material impact on our business, results of operations, financial condition and prospects. Failure to remain compliant
with the fulfillment practices on Amazon’s platform could have a material impact on our business, results of operations,
financial condition and prospects.
The
control deficiencies in our internal control over financial reporting may, until remedied, cause errors in our financial statements
or cause our filings with the SEC to not be timely.
As
of the end of the period covered by this Annual Report, our Certifying Officers have concluded that the Company’s disclosure
controls and procedures were not effective due to our limited internal audit functions and lack of ability to have multiple levels
of transaction review. We believe our disclosure controls and procedures were and remain not effective due to our limited internal
audit functions and lack of ability to have multiple levels of transaction review in our internal control over financial reporting
as of December 31, 2020, including those related to (i) a lack of segregation of duties within accounting functions, and (ii)
the need for a new accounting system to effectively manage our increased volume of transactions. If we do not remedy our internal
control over financial reporting or disclosure controls and procedures, there may be errors in our financial statements that could
require a restatement or our filings may not be timely made with the SEC. We intend to implement additional corporate governance
and control measures to strengthen our control environment as we are able, but we may not achieve our desired objectives. Moreover,
no control environment, no matter how well designed and operated, can prevent or detect all errors or fraud. We may identify material
weaknesses and control deficiencies in our internal control over financial reporting in the future that may require remediation
and could lead investors to lose confidence in our reported financial information, which could lead to a decline in our stock
price.
Breaches
of network or information technology security, natural disasters or terrorist attacks could have an adverse effect on our business.
Cyber-attacks
or other breaches of network or information technology (“IT”) security, natural disasters, terrorist acts or acts
of war may cause equipment failures or disrupt our systems and operations. We may be subject to attempts to breach the security
of our networks and IT infrastructure through cyber-attacks, malware, computer viruses and other means of unauthorized access.
A failure to protect the privacy of customer and employee confidential data against breaches of network or IT security could result
in damage to our reputation. To date, we have not been subject to cyber-attacks or other cyber incidents which, individually or
in the aggregate, resulted in a material impact to our operations or financial condition.
Non-compliance
with, or changes in, the legal and regulatory environment in the countries in which we operate could increase our costs or reduce
our net operating revenues.
Our
business is subject to various laws and regulations in the US and in the countries throughout the world in which we do business,
including laws and regulations relating to commerce, intellectual property, trade, environmental, health and safety, commerce
and contracts, privacy and communications, consumer protection, web services, tax, and state corporate laws and securities laws;
and specifically in the communications equipment industry, many of which are still evolving and could be interpreted in ways that
could harm our business. There is no assurance that we will be completely effective in ensuring our compliance with all applicable laws
and regulations. Changes in applicable laws or regulations or evolving interpretations thereof, including increased government
regulations, may result in increased compliance costs, capital expenditures and other financial obligations for us and could affect
our profitability or impede the production or distribution of our products, which could affect our net operating revenues.
Our
business activities may be subject to the Foreign Corrupt Practices Act (“FCPA”), the UK Bribery Act 2010 (“UK
Bribery Act”), and other similar anti-bribery and anti-corruption laws of other countries in which we operate.
We
have conducted and have ongoing business operations in international locations, and may in the future initiate business operations
in additional countries other than the U.S. Our business activities may be subject to the FCPA, the UK Bribery Act and other similar
anti-bribery or anti-corruption laws, regulations or rules of other countries in which we operate. The FCPA generally prohibits
offering, promising, giving or authorizing others to give anything of value, either directly or indirectly, to a non-U.S. government
official in order to influence official action or otherwise obtain or retain business. The FCPA also requires public companies
to make and keep books and records that accurately and fairly reflect the transactions of the corporation and to devise and maintain
an adequate system of internal accounting controls. Our business is regulated and therefore involves interaction with public officials,
including officials of non-U.S. governments. There is no certainty that all of our employees, agents or contractors, or those
of our affiliates, will comply with all applicable laws and regulations, particularly given the high level of complexity of these
laws. Violations of these laws and regulations could result in fines, criminal sanctions against us, our officers or our employees,
the closing down of our facilities, requirements to obtain export licenses, cessation of business activities in sanctioned countries,
implementation of compliance programs and prohibitions on the conduct of our business. Any such violations could include prohibitions
on our ability to offer our products in one or more countries and could materially damage our reputation, our brand, our international
expansion efforts, our ability to attract and retain employees and our business, prospects, operating results and financial condition.
12
Risks
Related to Our Securities
You
may experience dilution of your ownership interests because of the future issuance of additional shares of our common or preferred
stock or other securities that are convertible into or exercisable for our common or preferred stock.
We
are authorized to issue an aggregate of 50,000,000 shares of common stock and 3,333,333 shares of “blank check” preferred
stock. In the future, we may issue our authorized but previously unissued equity securities, resulting in the dilution of the
ownership interests of our present stockholders. We may issue additional shares of our common stock or other securities that are
convertible into or exercisable for our common stock in connection with hiring or retaining employees, future acquisitions, future
sales of our securities for capital raising purposes, or for other business purposes. The future issuance of any such additional
shares of our common stock may create downward pressure on the trading price of the common stock.
You
will experience future dilution as a result of future equity offerings.
We
may in the future offer additional shares of our common stock or other securities convertible into or exchangeable for our common
stock. Although no assurances can be given that we will consummate a financing, in the event we do, or in the event we sell shares
of common stock or other securities convertible into shares of our common stock in the future, additional and substantial dilution
will occur. In addition, investors purchasing shares or other securities in the future could have rights superior to investors
in this offering.
We
do not anticipate paying dividends on our common stock.
Cash
dividends have never been declared or paid on our common stock, and we do not anticipate such a declaration or payment for the
foreseeable future. We expect to use future earnings, if any, to fund business growth. Therefore, stockholders will not receive
any funds absent a sale of their shares of common stock. If we do not pay dividends, our common stock may be less valuable because
a return on your investment will only occur if our stock price appreciates. We cannot assure stockholders of a positive return
on their investment when they sell their shares, nor can we assure that stockholders will not lose the entire amount of their
investment.
Being
a public company is expensive and administratively burdensome.
As
a public reporting company, we are subject to the information and reporting requirements of the Securities Act of 1933, as amended
(the “Securities Act”), the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and other
federal securities laws, rules and regulations related thereto, including compliance with the Sarbanes-Oxley Act. Complying with
these laws and regulations requires the time and attention of our Board of Directors and management, and increases our expenses.
We estimate the Company will incur approximately $200,000 to $300,000 annually in connection with being a public company.
Among
other things, we are required to:
●
maintain
and evaluate a system of internal controls over financial reporting in compliance with the requirements of Section 404 of
the Sarbanes-Oxley Act and the related rules and regulations of the SEC and the Public Company Accounting Oversight Board;
●
prepare
and distribute periodic reports in compliance with our obligations under federal securities laws;
●
institute
a more comprehensive compliance function, including with respect to corporate governance; and
●
involve,
to a greater degree, our outside legal counsel and accountants in the above activities.
13
The
costs of preparing and filing annual and quarterly reports, proxy statements and other information with the SEC and furnishing
audited reports to stockholders are expensive and much greater than that of a privately-held company, and compliance with these
rules and regulations may require us to hire additional financial reporting, internal controls and other finance personnel, and
will involve a material increase in regulatory, legal and accounting expenses and the attention of management. There can be no
assurance that we will be able to comply with the applicable regulations in a timely manner, if at all. In addition, being a public
company makes it more expensive for us to obtain director and officer liability insurance. In the future, we may be required to
accept reduced coverage or incur substantially higher costs to obtain this coverage.
If
we fail to establish and maintain an effective system of internal control, we may not be able to report our financial results
accurately or to prevent fraud. Any inability to report and file our financial results accurately and timely could harm our reputation
and adversely impact the trading price of our common stock.
As
discussed above, to date, we have not been successful in maintaining an effective system of internal control.
Effective internal control is necessary for us to provide reliable financial reports and prevent fraud. If we cannot provide reliable
financial reports or prevent fraud, we may not be able to manage our business as effectively as we would if an effective control
environment existed, and our business and reputation with investors may be harmed. As a result, our small size and any current
internal control deficiencies may adversely affect our financial condition, results of operation and access to capital.
Public
company compliance may make it more difficult to attract and retain officers and directors.
The
Sarbanes-Oxley Act and rules subsequently implemented by the SEC have required changes in corporate governance practices of public
companies. As a public company, we expect these rules and regulations to increase our compliance costs in 2021 and beyond
and to make certain activities more time consuming and costly. As a public company, we also expect that these rules and regulations
may make it more difficult and expensive for us to obtain director and officer liability insurance in the future and we may be
required to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage.
As a result, it may be more difficult for us to attract and retain qualified persons to serve on our Board of Directors or as
executive officers.
The
ability of our Board of Directors to issue additional stock may prevent or make more difficult certain transactions, including
a sale or merger of the Company.
Our
Board of Directors is authorized to issue up to 3,333,333 shares of preferred stock with powers, rights and preferences designated
by it. See “Preferred Stock” in the section of this prospectus titled “Description of Securities.” Shares
of voting or convertible preferred stock could be issued, or rights to purchase such shares could be issued, to create voting
impediments or to frustrate persons seeking to effect a takeover or otherwise gain control of the Company. The ability of the
Board of Directors to issue such additional shares of preferred stock, with rights and preferences it deems advisable, could discourage
an attempt by a party to acquire control of the Company by tender offer or other means. Such issuances could therefore deprive
stockholders of benefits that could result from such an attempt, such as the realization of a premium over the market price for
their shares in a tender offer or the temporary increase in market price that such an attempt could cause. Moreover, the issuance
of such additional shares of preferred stock to persons friendly to the Board of Directors could make it more difficult to remove
incumbent officers and directors from office even if such change were to be favorable to stockholders generally.
Our
stock may be traded infrequently and in low volumes, so you may be unable to sell your shares at or near the quoted bid prices
if you need to sell your shares.
Until
our common stock is listed on a national securities exchange such as the New York Stock Exchange or the Nasdaq Stock Market, we
expect our common stock to remain eligible for quotation on the OTC Markets, or on another over-the-counter quotation system,
or in the “pink sheets.” In those venues, however, the shares of our common stock may trade infrequently and in low
volumes, meaning that the number of persons interested in purchasing our common shares at or near bid prices at any given time
may be relatively small or non-existent. An investor may find it difficult to obtain accurate quotations as to the market value
of our common stock or to sell his or her shares at or near bid prices or at all. In addition, if we fail to meet the criteria
set forth in SEC regulations, various requirements would be imposed by law on broker-dealers who sell our securities to persons
other than established customers and accredited investors. Consequently, such regulations may deter broker-dealers from recommending
or selling our common stock, which may further affect the liquidity of our common stock. This would also make it more difficult
for us to raise capital.
14
There
currently is no active public market for our common stock and there can be no assurance that an active public market will ever
develop. Failure to develop or maintain a trading market could negatively affect the value of our common stock and make it difficult
or impossible for you to sell your shares.
There
is currently no active public market for shares of our common stock and one may never develop. Our common stock is quoted on the
OTC Markets. The OTC Markets is a thinly traded market and lacks the liquidity of certain other public markets with which some
investors may have more experience. We may not ever be able to satisfy the listing requirements for our common stock to be listed
on a national securities exchange, which is often a more widely-traded and liquid market. Some, but not all, of the factors which
may delay or prevent the listing of our common stock on a more widely-traded and liquid market include the following: our stockholders’
equity may be insufficient; the market value of our outstanding securities may be too low; our net income from operations may
be too low; our common stock may not be sufficiently widely held; we may not be able to secure market makers for our common stock;
and we may fail to meet the rules and requirements mandated by the several exchanges and markets to have our common stock listed.
Should we fail to satisfy the initial listing standards of the national exchanges, or our common stock is otherwise rejected for
listing, and remains listed on the OTC Markets or is suspended from the OTC Markets, the trading price of our common stock could
suffer and the trading market for our common stock may be less liquid and our common stock price may be subject to increased volatility,
making it difficult or impossible to sell shares of our common stock.
Our
common stock is subject to the “penny stock” rules of the SEC and the trading market in the securities is limited,
which makes transactions in the stock cumbersome and may reduce the value of an investment in the stock.
Rule
15g-9 under the Exchange Act establishes the definition of a “penny stock,” for the purposes relevant to us, as any
equity security that has a market price of less than $5.00 per share or with an exercise price of less than $5.00 per share, subject
to certain exceptions. For any transaction involving a penny stock, unless exempt, the rules require: (a) that a broker or dealer
approve a person’s account for transactions in penny stocks; and (b) the broker or dealer receive from the investor a written
agreement to the transaction, setting forth the identity and quantity of the penny stock to be purchased. In order to approve
a person’s account for transactions in penny stocks, the broker or dealer must: (a) obtain financial information and investment
experience objectives of the person and (b) make a reasonable determination that the transactions in penny stocks are suitable
for that person and the person has sufficient knowledge and experience in financial matters to be capable of evaluating the risks
of transactions in penny stocks. The broker or dealer must also deliver, prior to any transaction in a penny stock, a disclosure
schedule prescribed by the SEC relating to the penny stock market, which, in highlight form: (a) sets forth the basis on which
the broker or dealer made the suitability determination; and (b) confirms that the broker or dealer received a signed, written
agreement from the investor prior to the transaction. Generally, brokers may be less willing to execute transactions in securities
subject to the “penny stock” rules. This may make it more difficult for investors to dispose of our common stock and
cause a decline in the market value of our common stock. Disclosure also has to be made about the risks of investing in penny
stocks in both public offerings and in secondary trading and about the commissions payable to both the broker or dealer and the
registered representative, current quotations for the securities and the rights and remedies available to an investor in cases
of fraud in penny stock transactions. Finally, monthly statements have to be sent disclosing recent price information for the
penny stock held in the account and information on the limited market in penny stocks.
15
Our
stock price may be volatile.
The
market price of our common stock is likely to be highly volatile and could fluctuate widely in price in response to various factors,
many of which are beyond our control, including the following:
●
changes
in our industry;
●
competitive
pricing pressures;
●
our
ability to obtain working capital financing;
●
additions
or departures of key personnel;
●
sales
of our common stock;
●
our
ability to execute our business plan;
●
operating
results that fall below expectations;
●
loss
of any strategic relationship;
●
regulatory
developments; and
●
economic
and other external factors.
In
addition, the securities markets have from time to time experienced significant price and volume fluctuations that are unrelated
to the operating performance of particular companies. These market fluctuations may also materially and adversely affect the market
price of our common stock.
Offers
or availability for sale of a substantial number of shares of our common stock may cause the price of our common stock to decline.
If
our stockholders sell substantial amounts of our common stock in the public market, including upon the expiration of any statutory
holding period under Rule 144, or issued upon the conversion of preferred stock or exercise of warrants, it could create a circumstance
commonly referred to as an “overhang” and in anticipation of which the market price of our common stock could fall.
The existence of an overhang, whether or not sales have occurred or are occurring, also could make more difficult our ability
to raise additional financing through the sale of equity or equity-related securities in the future at a time and price that we
deem reasonable or appropriate.
Investor
relations activities, nominal “float” and supply and demand factors may affect the price of our stock.
The
Company expects to utilize various techniques such as non-deal road shows and investor relations campaigns in order to create
investor awareness for the Company. These campaigns may include personal, video and telephone conferences with investors and prospective
investors in which our business practices are described. The Company may provide compensation to investor relations firms and
pay for newsletters, websites, mailings and email campaigns that are produced by third-parties based upon publicly-available information
concerning the Company. The Company does not intend to review or approve the content of such analysts’ reports or other
materials based upon analysts’ own research or methods. Investor relations firms should generally disclose when they are
compensated for their efforts, but whether such disclosure is made or complete is not under our control. In addition, investors
in the Company may, from time to time, also take steps to encourage investor awareness through similar activities that may be
undertaken at the expense of the investors. Investor awareness activities may also be suspended or discontinued which may impact
the trading market our common stock.
16
The
SEC and FINRA enforce various statutes and regulations intended to prevent manipulative or deceptive devices in connection with
the purchase or sale of any security and carefully scrutinize trading patterns and company news and other communications for false
or misleading information, particularly in cases where the hallmarks of “pump and dump” activities may exist, such
as rapid share price increases or decreases. We, and our shareholders may be subjected to enhanced regulatory scrutiny due to
the small number of holders who initially will own the registered shares of our common stock publicly available for resale, and
the limited trading markets in which such shares may be offered or sold which have often been associated with improper activities
concerning penny-stocks, such as the OTCQB Marketplace or the OTCPink Marketplace (Pink OTC) or pink sheets. Until such time as
our restricted shares are registered or available for resale under Rule 144, there will continue to be a small percentage of shares
held by a small number of investors, many of whom acquired such shares in privately negotiated purchase and sale transactions,
which will constitute the entire available trading market. The Supreme Court has stated that manipulative action is a term of
art connoting intentional or willful conduct designed to deceive or defraud investors by controlling or artificially affecting
the price of securities. Often times, manipulation is associated by regulators with forces that upset the supply and demand factors
that would normally determine trading prices. Since a small percentage of the outstanding common stock of the Company will initially
be available for trading, held by a small number of individuals or entities, the supply of our common stock for sale will be extremely
limited for an indeterminate amount of time, which could result in higher bids, asks or sales prices than would otherwise exist.
Securities regulators have often cited factors such as thinly-traded markets, small numbers of holders, and awareness campaigns
as hallmarks of claims of price manipulation and other violations of law when combined with manipulative trading, such as wash
sales, matched orders or other manipulative trading timed to coincide with false or touting press releases. There can be no assurance
that the Company’s or third-parties’ activities, or the small number of potential sellers or small percentage of stock
in the “float,” or determinations by purchasers or holders as to when or under what circumstances or at what prices
they may be willing to buy or sell stock will not artificially impact (or would be claimed by regulators to have affected) the
normal supply and demand factors that determine the price of the stock.
Item
1B. Unresolved Staff Comments
Not
applicable.
Item
2. Description of Property.
We
rent our office space at 18851 N.E. 29th Ave, Suite 700, Aventura, Florida 33180 for $314 per month and our facilities in Poole,
England for £2,128 (or approximately US$2,717) per month. We estimate that this property will meet the Company’s
needs for the foreseeable future.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.